CD133 + circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients
2010
CD133 + circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
48
References
30
Citations
NaN
KQI